◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

Home › All stocks › S › SKR

Sikarin Public Company Limited (SKR) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Care Facilities · DATA UPDATED 2026-08-22

Sikarin Public Company Limited (SKR) operates in the Medical Care Facilities industry and is headquartered in Bangkok, Thailand with about 3,073 employees. Its market capitalization is roughly THB 16 billion. In the fiscal year ended 2025-12-31, SKR reported THB 6.0B in revenue and THB 752M in net income.

Sikarin Public Company Limited, together with its subsidiaries, operates hospitals in Thailand.

Interactive charts & full statements →

SKR Revenue & Earnings History — Annual Income Statement

Income statement	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Revenue	THB 6.0B	THB 6.1B	THB 5.8B	THB 5.7B	—
Gross Profit	THB 1.8B	THB 1.8B	THB 2.0B	THB 2.0B	—
Operating Income (EBIT)	THB 937M	THB 833M	THB 1.1B	THB 1.3B	—
Net Income	THB 752M	THB 664M	THB 891M	THB 1.0B	—

THB; THBM / THBB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SKR Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31
Total Revenue	THB 1.4B	THB 1.4B	THB 1.6B	THB 1.5B	THB 1.5B
Gross Profit	THB 377M	THB 408M	THB 455M	THB 487M	THB 470M
Operating Income (EBIT)	THB 155M	THB 187M	THB 233M	THB 261M	THB 256M
Net Income	THB 126M	THB 150M	THB 187M	THB 208M	THB 207M

THB; THBM / THBB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SKR Free Cash Flow History

Cash flow	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Dividends Paid	(THB 411M)	(THB 370M)	(THB 350M)	(THB 411M)	—

THB; THBM / THBB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SKR Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Dividends Paid	THB 0M	(THB 0M)	(THB 183M)	(THB 228M)	THB 0M	—

THB; THBM / THBB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

SKR Balance Sheet History

Balance sheet	2025-12-31	2024-12-31	2023-12-31	2022-12-31	2021-12-31
Total Assets	THB 9.6B	THB 9.6B	THB 9.2B	THB 8.8B	—
Total Liabilities	THB 1.7B	THB 1.9B	THB 1.8B	THB 1.9B	—

THB; THBM / THBB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SKR viewer.

Other Companies in Medical Care Facilities

7071 · Amvis Holdings, Inc. — JPY 38 billion
FRE · Fresenius SE & Co. KGaA — €26 billion
VIBHA · Vibhavadi Medical Center Public Company Limited — THB 18 billion
CHG · Chularat Hospital Public Company Limited — THB 18 billion
PR9 · Praram 9 Hospital Public Company Limited — THB 15 billion
FME · Fresenius Medical Care AG — €11 billion
8769 · Advantage Risk Management Co., Ltd. — JPY 8 billion
MEDEZE · MEDEZE_MEDEZE GROUP — THB 7 billion

← SKOR All “S” companies SKRE →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.